Clinical Trial Update: Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the safety of a meningococcal polysaccharide diphtheria toxoid conjugate vaccine in healthy Vietnamese adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Meningococcal Infections

Drugs mentioned

• Meningococcal polysaccharide diphtheria toxoid conjugate vaccine (Groups A, C, Y and W-135) (Meningococcal polysaccharide diphtheria toxoid conjugate vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningitis, Meningococcal Meningitis | Phase 2 | Status: COMPLETED | Results posted: 2018-01-08